TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

TRANSFORMATIVE PHARMACEUTICAL SOLUTIONS

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

TRANSFORMATIVE PHARMACEUTICAL SOLUTIONS

ST13

US500000086794366

Classe

35

Pedido

86794366

Registro

5617769

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

49

Atualização mais recente

16/10/2024

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

35

Data de depósito

21/10/2015

Data de registro

27/11/2018

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

16/10/2024

Última transação

16/10/2024

Escritório responsável

United States Patent and Trademark Office

Código da situação

702

Cadastro oficial

Principal Register

Fundamento do pedido

Intent to use

Primeiro uso

2016-09-00

Primeiro uso no comércio

2016-09-00

Código do desenho

4

Tipo de titular

16

Localização do titular

Blue Bell, PA, US

Examinador

MURRAY, GEORGE WILLIAM

Localização atual

Historical data usage

Titulares e representantes

Titulares

Transformative Pharmaceutical Solutions, LLC

Representantes

Susan A. Smith Ballard Spahr LLP

Classificação técnica

Classes Nice

Classe 35

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 35

clinical research site management and monitoring, namely, identifying, qualifying, and selecting sites for clinical trials, negotiating clinical trial site contracts and budgets, organizing and conducting business meetings of clinical trial investigators, assisting investigators with developing business strategies for recruiting clinical trial participants, submitting clinical trial protocols to institutional review boards and independent ethics committees, monitoring clinical trial investigators' activities for compliance with clinical protocols and regulations and for patient safety; employment staffing in the field of clinical trials; business information management; business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, pharmaceutical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; business project management in the field of clinical trials; providing the services of vendor management to medical, pharmaceutical, biopharmaceutical and biotechnology companies, namely, selecting and managing third-party providers of services that support clinical trials

Publicações

Histórico de despachos e eventos da marca no USPTO.

49 publicações encontradas

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

16/10/2024

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

16/10/2024

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

16/10/2024

E815

TEAS SECTION 8 & 15 RECEIVED

17/04/2024

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

27/11/2023

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

27/09/2022

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

27/09/2022

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

27/09/2022

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

27/09/2022

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

27/09/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

27/11/2018

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

26/10/2018

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

25/10/2018

SUPC

STATEMENT OF USE PROCESSING COMPLETE

25/10/2018

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

25/10/2018

IUAF

USE AMENDMENT FILED

01/10/2018

EISU

TEAS STATEMENT OF USE RECEIVED

01/10/2018

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

15/03/2018

EX1G

SOU EXTENSION 1 GRANTED

13/03/2018

EXT1

SOU EXTENSION 1 FILED

13/03/2018

EEXT

SOU TEAS EXTENSION RECEIVED

13/03/2018

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

28/11/2017

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

18/10/2017

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

18/10/2017

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/10/2017

PUBO

PUBLISHED FOR OPPOSITION

03/10/2017

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

13/09/2017

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

28/08/2017

RCCK

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

22/08/2017

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

16/02/2017

GNSL

LETTER OF SUSPENSION E-MAILED

16/02/2017

CNSL

SUSPENSION LETTER WRITTEN

16/02/2017

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

08/02/2017

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/02/2017

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

08/02/2017

RCSC

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

16/12/2016

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

16/06/2016

GNSL

LETTER OF SUSPENSION E-MAILED

16/06/2016

CNSL

SUSPENSION LETTER WRITTEN

16/06/2016

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/06/2016

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/06/2016

ALIE

ASSIGNED TO LIE

02/06/2016

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

20/05/2016

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

19/02/2016

GNRT

NON-FINAL ACTION E-MAILED

19/02/2016

CNRT

NON-FINAL ACTION WRITTEN

19/02/2016

DOCK

ASSIGNED TO EXAMINER

11/02/2016

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

26/10/2015

NWAP

NEW APPLICATION ENTERED

24/10/2015

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace TRANSFORMATIVE PHARMACEUTICAL SOLUTIONS ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.